Hypolipidemic Agents: all 738 studies that test it

Page 7 of 8. Open to participants first (69), then studies with results posted, then the rest; newest registration first within each.

• A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 DiabetesCompletedNCT00703482Phase 2
• Safety and Benefit of MBX-8025 With and Without Commonly Used Statins in Moderately Overweight Patients With High CholesterolCompletedNCT00701883Phase 2
• The Effect of Simvastatin on Desensitization of Panel-Positive Kidney Transplant CandidatesCompletedNCT00693576Phase 2/3
• Effect of Choline Fenofibrate (SLV348) on Macular EdemaCompletedNCT00683176Phase 2
• A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and EzetimibeCompletedNCT00681525Phase 1
• Simvastatin in Chronic Obstructive Pulmonary Disease (COPD)Status unknownNCT00680641Phase 4
• Losartan and Simvastatin in Hypertensive Obeses With Liver SteatosisStatus unknownNCT00669435Phase 4
• Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to PlaceboCompletedNCT00668343Phase 3
• Standard Medical Management in Secondary Prevention of Ischemic Stroke in ChinaCompletedNCT00664846Not applicable
• Extended Release (ER) Niacin/Laropiprant Add on Study (0524A-082)WithdrawnNCT00664287Phase 3
• Effect of Statin Therapy on C-reactive Protein Levels in Patients With Chronic Obstructive Lung Disease (COPD)CompletedNCT00655993Phase 1
• Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435)CompletedNCT00653835Phase 4
• Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2)CompletedNCT00652431Phase 1
• A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol (0653-050)(COMPLETED)CompletedNCT00652301Phase 3
• Vytorin As Strategy To Reduce Dislipidemia In Adults (0653A-148)CompletedNCT00651560Phase 3
• Effect of Ezetimibe Plus Simvastatin on Flow-Mediated Brachial Artery Vasoactivity in Subjects With Primary Hypercholesterolemia (Study P03336)TerminatedNCT00651391Phase 3
• Comparison of Ezetimibe Plus Simvastatin Versus Ezetimibe or Simvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03757)(COMPLETED)CompletedNCT00650819Phase 3
• Ezetimibe Plus Simvastatin Versus Simvastatin Alone in African-American Subjects With Primary Hypercholesterolemia (P03377)CompletedNCT00650663Phase 4
• Evaluation of the Effect of NICOtinic Acid (Niacin) on Elevated Lipoprotein(a) Levels (NICOLa Study)Status unknownNCT00633698Phase 3
• Pharmacological Regulation of Fat Transport in Metabolic SyndromeCompletedNCT00632840Phase 4
• Effect of a PPAR-Alpha Agonist on the Age Related Changes in Myocardial Metabolism and Mechanical FunctionStatus unknownNCT00627653Not applicable
• Add-on Simvastatin in Schizophrenia TrialTerminatedNCT00605995Not applicable
• Efficacy and Safety of Simvastatin in the Treatment of Portal HypertensionCompletedNCT00594191Phase 2
• Benefit of Elevation of HDL-C on Cardiovascular Outcomes in WomenCompletedNCT00590629Phase 4
• The Acute Effect of Statins on Inflammatory Markers of Athersclerotic TissueCompletedNCT00587717Not applicable
• Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered ConcomitantlyCompletedNCT00585143Phase 1
• Effects of Simvastatin on Biochemical Parameters and Outcome of IVF-ICSI in Pcos PatientsCompletedNCT00575601Phase 3
• Drug-Drug Interaction Study of Mitiglinide and GemfibrozilCompletedNCT00566865Phase 1
• A Randomized, Double-Blinded Study of Simvastatin 20 mg/Day Versus Vytorin 10/20 in Subjects With Lipid Profiles Not Meeting Current NCEP Guidelines, Following a Low-Carbohydrate DietCompletedNCT00566267Phase 2/3
• Vascular Effects of Ezetimibe/Simvastatin and Simvastatin on AtherosclerosisCompletedNCT00560170Phase 4
• Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart DiseaseCompletedNCT00552747Phase 4
• Effect of 4 Weeks Treatment With Acipimox in Patients With Chronic Heart FailureCompletedNCT00549614Not applicable
• Impact of Benfluorex Versus Metformin on Glucose Control and Insulin Secretion in Chinese Type 2 Diabetic PatientsStatus unknownNCT00544518Phase 2
• Effect of Fenofibrate on Kidney Function: a Six-week Randomized Cross-over Trial in Healthy PeopleCompletedNCT00543647Phase 1
• Simvatstatin Used to Treat Pulmonary HypertensionStatus unknownNCT00538044Phase 1
• Evaluate the Efficacy and Safety of Rosuvastatin Versus Simvastatin in Type 2 Diabetic Patients With DyslipidemiaCompletedNCT00506961Phase 4
• Study of CRx-401 on Glucose Levels in Subjects With Type II DiabetesCompletedNCT00506298Phase 2
• A Study To Evaluate The Safety And Tolerability Of SB-656933-AAA Following Repeated Doses In Healthy Adult SubjectsCompletedNCT00504439Phase 1
• Efficacy and Safety of Statin on the Course of Progressive Smoldering Multiple MyelomaWithdrawnNCT00503763Phase 2
• Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple SclerosisCompletedNCT00492765Phase 4
• Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and DyslipidemiaCompletedNCT00490178Phase 3
• Interaction Between ABT-335, Rosuvastatin and WarfarinCompletedNCT00487136Phase 1
• Tissue Lipids and Insulin ResistanceWithdrawnNCT00483210Not applicable
• Simvastatin Reduces Circulating Osteoprotegerin Levels in Patients With Type 2 DiabetesCompletedNCT00471549Phase 4
• Effect of Ezetimibe on Platelet Aggregation and LDL Tendency to PeroxidationCompletedNCT00466401Phase 4
• Comparison of Efficacy and Safety of Ezetimibe or Statin Monotherapy to Co-Administration of BothCompletedNCT00461968Not applicable
• High-Density Lipoprotein (HDL) Treatment StudyCompletedNCT00458055Not applicable
• Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC)CompletedNCT00452634Phase 2
• Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00452244Phase 2
• Cholesterol and Pharmacogenetic StudyCompletedNCT00451828Phase 4
• Simvastatin in Patients With Septic ShockStatus unknownNCT00450840Phase 4
• Metabolic Modulation as Treatment in Acute Heart FailureTerminatedNCT00449423Phase 2
• Monocyte Function and Inflammation in Type 1 Diabetes and Its ModulationCompletedNCT00441844Phase 2
• Niacin As Secondary Prevention Of Coronary Artery Disease (NASPOCAD)Status unknownNCT00431145Phase 2
• Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple SclerosisWithdrawnNCT00429442Phase 3
• Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and ThrombosisCompletedNCT00422396Not applicable
• Oxidative Stress Lowering Effect of Simvastatin and Atorvastatin.Status unknownNCT00404599Phase 4
• The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) StudyCompletedNCT00400231Phase 2
• Simvastatin as Inhibitor of Cell Adhesion Mediated Drug Resistance in Patients With Refractory Multiple Myeloma.CompletedNCT00399867Phase 2
• Evaluation of the Effects of Simvastatin 40mgCompletedNCT00397826Phase 4
• Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on AtherosclerosisTerminatedNCT00397657Phase 4
• Simvastatin and Metformin Therapy in PCOS Women. Prospective Randomised Trial.Status unknownNCT00396513Not applicable
• Efficacy and Safety of Valsartan and the Combination of Valsartan and SimvastatinCompletedNCT00385931Phase 3
• Tolerability of MK0524A Versus Niacin Extended-Release (0524A-054)CompletedNCT00378833Phase 3
• A Drug-Drug Interaction Study of GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes.CompletedNCT00377442Phase 1
• Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of CP-742,033WithdrawnNCT00376285Phase 1
• Statin Therapy Vs. Therapeutic Lifestyle Changes and SupplementsCompletedNCT00365742Not applicable
• Simvastatin Therapy in Women With Polycystic Ovary Syndrome.CompletedNCT00365638Not applicable
• A Drug Interaction Study Between Tocilizumab, Methotrexate and Simvastatin on Patients With Rheumatoid Arthritis.CompletedNCT00365001Phase 1
• Comparison of the Combination of Fenofibrate and Simvastatin Versus AtorvastatinCompletedNCT00362934Phase 3
• Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics StudyTerminatedNCT00362765Phase 2/3
• Comparison of the Combination of Fenofibrate and Simvastatin Versus PravastatinCompletedNCT00362206Phase 3
• Substrate Cycling in Energy MetabolismCompletedNCT00361751Phase 2
• Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg Simvastatin MonotherapyCompletedNCT00352183Phase 3
• Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial FunctionsCompletedNCT00350038Phase 4
• A Controlled-Study on the Effect of a Combination of Fenofibrate and Metformin on Weight Loss and Weight Loss-Maintenance, in Obese Patients.CompletedNCT00349635Phase 2
• Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin MonotherapyCompletedNCT00349375Phase 3
• A Controlled-Study of Fenofibrate 145 mg and Ezetimibe 10 mg in Type IIb Dyslipidemic Patients With Features of the Metabolic SyndromeCompletedNCT00349284Phase 3
• Fenofibrate in Dyslipidemia and Metformin-Controlled DiabetesCompletedNCT00349128Phase 2/3
• Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual CareCompletedNCT00345657Phase 4
• Bezafibrate Trial in CPT2 DeficiencyStatus unknownNCT00336167Phase 3
• Effects of Statin Medications on Mental Processes, Behavior, and Serotonin LevelsCompletedNCT00330980Phase 4
• Paroxysmal Atrial Fibrillation: Role of Inflammation, Oxidative Stress Injury and Effect of StatinsCompletedNCT00321802Phase 2
• LDL Receptor Under Ezetimibe and SimvastatinCompletedNCT00317993Phase 4
• Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and HypercholesterolemiaCompletedNCT00316095Phase 3
• Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRCCompletedNCT00313859Phase 2
• Diabetes and Combined Lipid Therapy Regimen (DIACOR) StudyCompletedNCT00309712Not applicable
• Pioglitazone in Impaired Glucose ToleranceWithdrawnNCT00306826Phase 4
• Study of Niacin and Rosiglitazone in Dysmetabolic DyslipidemiaCompletedNCT00304993Phase 4
• Do HMG CoA Reductase Inhibitors Affect Abeta Levels?CompletedNCT00303277Phase 4
• Exercise Versus Niacin in Patients With Coronary Artery Disease (CAD) and Low High-Density Lipoproteins (HDL)CompletedNCT00298909Phase 4
• Simvastatin Effect on End Stage Renal Failure Patients Treated by Peritoneal DialysisStatus unknownNCT00291863Phase 4
• Effects of Statins on Pro- and Antioxidant Status : Link With Statin-Associated Myopathy.CompletedNCT00285181Not applicable
• The VA HDL Intervention Trial (HIT): Secondary Prevention of Coronary Heart Disease in Men With Low HDL-Cholesterol and Desirable LDL-CholesterolCompletedNCT00283335Phase 3
• The Effect of High Dose Simvastatine on Multiple MyelomaCompletedNCT00281476Phase 1/2
• A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031).TerminatedNCT00267280Phase 3
• A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol.CompletedNCT00267254Phase 3
• GALLANT 14 Tesaglitazar vs. Metformin and FenofibrateTerminatedNCT00261352Phase 3
• Simvastatin Treatment of Patients With Acute Optic NeuritisStatus unknownNCT00261326Phase 3
• PROMISS: Simvastatin Prevents the Contrast Induced Acute Renal Failure in Patients With Renal Insufficiency Undergoing Coronary AngiographyCompletedNCT00259441Phase 4

← Hypolipidemic Agents overview